• IMMURON LTD (IMC) - Travelan's Record-Breaking Success Puts Immuron on the Global Health Map

  • Apr 20 2025
  • Duración: 13 m
  • Podcast

IMMURON LTD (IMC) - Travelan's Record-Breaking Success Puts Immuron on the Global Health Map

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • Send us a text

    Steve Lydeamore, CEO of Immuron Limited, takes us behind the scenes of one of Australia's most innovative biopharmaceutical companies. What makes this Melbourne-based biotech unique is their dual focus—a thriving commercial product alongside a promising technology platform targeting infectious diseases.

    The spotlight falls on Travelan, Immuron's preventative treatment for traveller's diarrhoea that has experienced phenomenal growth. After sales plummeted to near-zero during the pandemic, the company has ssen a remarkable turnaround from $145,000 to over $5.3 million in less than a year. This success story involved strengthening pharmacy distribution networks across Australia and Canada while leveraging Amazon as their primary channel in the US market. As international travel rebounds, particularly to high-risk regions like Bali and Vietnam, Travelan's unique preventative approach—"nobody wants to get it"—positions it perfectly for continued growth.
    Más Menos
Más Menos
adbl_web_global_use_to_activate_webcro768_stickypopup

Lo que los oyentes dicen sobre IMMURON LTD (IMC) - Travelan's Record-Breaking Success Puts Immuron on the Global Health Map

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles